55Score
ALNY
Alnylam Pharmaceuticals, Inc.
Health Care
NasdaqGSNasdaq 100
Risk: HIGH41
11
20
10
252.26USD
HOLDSwing Trade Setup & Plan
⚪ Neutral💡 Market consolidating or mixed signals. Wait for a clear directional catalyst.
⚪ NEUTRAL Signal (Market consolidating — No trade recommended)
Current Price$252.26Current Market Price
Support Level (SMA20)$244.07Watch for Dip Buy (-3.2%)
Resistance Level (SMA50)$255.43Watch for Breakout (+1.3%)
52-Week High~$491.22Distance from 52W High: -48.6%
💡 No trade recommended right now. Wait for either a healthy pullback to support with cooled RSI (Dip Buy) or a high-volume breakout above resistance (Breakout Buy).
Trend Structure:Death Cross → Recovering37/100
Momentum:RSI 59, 3.4% vs 20MA80/100
52W Strength:-49.1% from 52W High25/100
Rel. Volume:0.39x avg (Accum.)50/100
Risk Profile:ATR 1.9% of price, SI 6.3%75/100
Earnings Calendar:48d to earnings60/100
Market Regime:🟡 Neutral
⚠ Technical levels and targets are quantitatively calculated based on ATR volatility dynamics and price structure. Apply disciplined risk management.
All-Time Range
31.41491.22
NOW
Current price compared to the all-time low and high. A high position may indicate strong momentum.
Wall St. Target
371.35+47.21%
256.00536.00
AVG
NOW
Average analyst price target for the next 12 months.
-46.17%1Y
Explore All Stocks
Find Your Next Winning Stock on Aristockrat
Screen 500+ US & European equities with automated Peter Lynch multiples, Graham numbers, transparent health scores, and insider transactions.